Dr. Jens Gertow received his PhD in immunology from the Karolinska Institutet, Stockholm, Sweden, where he focused on immunotherapy using virus specific T cells. As a post-doc, he turned his attention towards respiratory tract dendritic cells and their interaction with Influenza A virus with an aim to improve therapeutic strategies. At Mabtech he works as a senior scientist with a special interest in novel applications for the FluoroSpot technique.
back to speakers